BRANDI POTTER-HARE: Open Payments
NPI 1144737990 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 76 payments from 15 companies in 2025. Trend: 2023 $738 · 2024 $1,661 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $346 |
| ABBVIE INC. | 17 | $227 |
| Novo Nordisk Inc | 12 | $152 |
| MERZ NORTH AMERICA, INC. | 3 | $151 |
| Ardelyx, Inc. | 2 | $139 |
| Lilly USA, LLC | 10 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Dexcom, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 1 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
Products named: REPATHA, OTEZLA, Xeomin, IBSRELA, UBRELVY, MOUNJARO, TZIELD, Ozempic.
Industry payments across SC — which companies pay providers there.
